The foundation of PHUSE's events lies in the submitted presentation content. PHUSE have long acknowledged those who contribute exceptional content to drive our event agenda's forward, and this commitment to recognising the best contributors remains steadfast.
| Category | Poster Title | Author(s) | View Poster |
|---|---|---|---|
Industry | PP18: Bridging the Gap – Enhancing Analysis Results Generation with the CDISC ARS Model and the Community TFL Designer | Bhavin Busa, Clymb Clinical | View Now |
Collaboration | PP03: SEND (Standard for Exchange of Nonclinical Data) Industry Feedback Survey: 2024 Results | Vanessa Chavez, Labcorp & Lindsy Eickhoff, Inotiv | View Now |
FDA | PP23: A Framework Enabling LLMS into Regulatory Environment for Transparency and trustworthiness and its Application to Drug Labelling Document | Shraddha Thakkar, FDA | View Now |
| Stream | Presentation Title | Author(s) | View Presentation |
|---|---|---|---|
Analytical Risk-based Monitoring | AR01: My Data Is Too Good to Be True! Should I Worry About Fraud or Sloppiness? | Michael Walega, Bristol Myers Squibb & Johann Proeve, Cyntegrity | View Now |
Analytics & Statistics | AS05: Spline Analysis to Understand the Non-linear Relationship in Clinical Research | Anwaya Joshi, Cytel | View Now |
Data Handling & Engineering | DH02: Eliminating SDTM Double Programming by Using a Validation Tool and Dummy Data | Glenn Borgmans & Tine Seeuws, SGS Health Science | View Now |
Data Standards & Governance | DS05: Approaching End-to-End Analysis Standardisation in Global and Therapeutic Areas Level | Rudra Sheth & Xiaohan Zou, Bristol Myers Squibb | View Now |
Data Visualisation | DV05: Statistical Monitoring Report: A Path Forward to Interactive Data Analysis and Quantitative Decision-Making | Debopriya Ghosh & Xiang Li, Johnson & Johnson | View Now |
Emerging Trends | ET08: AI Exploration and Innovation for the Clinical Data Scientist | Cole Arendt & Phil Bowsher, Posit | View Now |
Open Source Technologies | OS03: NEST: How Could We Generate and Deliver Clinical Insights Even Faster? | Vincent Shen, Roche | View Now |
People Leadership & Management | PM03: Leadership Insights – Let’s Learn How to Lead the Leaders | Rachna Mittal, Genentech | View Now |
Poster Presentations | PP07: Sowing Seeds of Inspiration: Letters to a Pre-Scientist | Julie Ann Hood, Pinnacle 21 by Certara | View Now |
Professional Development | PD03: Recruiting the Best Talent and Developing them within the Organisation | Madhusudhan Reddy Papasani & Naveen Kommurur, Merck | View Now |
Real-world Evidence | RE03: Future Clinical Data Submission Standards: CDISC, FHIR, OMOP, or Hybrid Model | Jeffrey Abolafia, Pinnacle 21 by Certara | View Now |
Scripts, Macros & Automation | SM10: A Practical Approach to Automating SDTM Using a Metadata-Driven Method that Leverages eCRF Specifications and SDTM Programming Standards | Xiangchen (Bob) Cui & Min Chen, CRISPR Therapeutics | View Now |
Standards Implementation | SI02: Automating ADaM Creation in Clinical Trials Part 2 | Rie Ichihashi & Lyubov Sushchenko, Sanofi | View Now |
Submissions & Agencies | SA03: Demystifying Submissions to NMPA China | Dyuthi Yellamraju & Hiral Raval, Genentech | View Now |
Therapeutic Areas Specific Topics | TA04: Are Platform Trials the Need of the Hour for Oncology Trials? | Vidya Muthukumar, IQVIA | View Now |
| Stream | Presentation Title | Author(s) | View Presentation |
|---|---|---|---|
Application Development | AD15: Janssen DATA4YOU Platform Approach for Clinical Data Review | Erik Lemmens & Paul Foole, Johnson & Johnson | View Now |
Analytical Risk-based Monitoring | AR07: Risk-Based Monitoring in Clinical Trials with Machine-Learning-Powered Anomaly Detection | Ece Kavalci & Zaid Al-Jubouri, Lindus Health | View Now |
Analytics & Statistics | AS10: Comparison of Power Between Different Recurrent Events Analysis Methods Using Simulation | Soumitra Kar, Novo Nordisk | View Now |
Coding Tips & Tricks | CT05: Dynamic Testing for Empty Datasets | Timothy Lachlan-Cope, AstraZeneca | View Now |
Connected Health & Machine Learning | CM06: Unleashing the Power of Large Language Models for Clinical Data Approaches: Will AI Chatbots such as ChatGPT/Bard Replace Statistical Programmers and Statisticians Over Time? | Ercan Suekuer, Roche | View Now |
Data Handling & Data Engineering | DH02: How Can Python Be Used in Clinical Trials? | Pierre Dostie & András Kása, UCB Biosciences | View Now |
Data Standards & Governance | DS07: Automated Pipelines for Non-CRF Value-Level Metadata: A Meta-Programming Approach | Selena Baset & Philipp Thomas Ernst, Roche | View Now |
Data Visualisation | DV01: Will R/Shiny Provide a Novel Way for Study Teams to Review Clinical Data? | Gustav Söderström, AstraZeneca | View Now |
Leadership Through Innovation | LI03: Road to Rome or Roaming – A Reprise | Christian Müller, Roche & Francis Kendall, AstraZeneca | View Now |
Professional Development | PD05: Mastering the Art of Adaptation: Innovative Strategies for Effective Change Management | Mark Bynens, Johnson & Johnson | View Now |
People Leadership & Management | PM06: Statistical Programming – Hiring Mission Made Possible | Christoph Ziegler & Donald Paterson, Johnson & Johnson | View Now |
Poster Presentations | PP16: CDISC’s ADTTE Domain: Time-to-Event Analysis From a Programmer’s Point of View | Vitali Gering & Sophia Praeger, Chrestos Concept | View Now |
Real-world Evidence | RE06: The Curious Case of Observational Studies – A Programmer’s Dilemma | Vikas Shokeen, Novartis | View Now |
Submissions & Agencies | SA07: Development Safety Update Report (DSUR)/Periodic Safety Update Report (PSUR) | Phillip Spowart, Fortrea | View Now |
Software Demonstrations | SD04: Digitalisation of Specifications – Enabling the Next Generation of Clinical Trials | Rebecca Bates & Nekzad Shroff, Saama Technologies | View Now |
Standards Implementation | SI02: Oak Garden – Metadata-Driven SDTM Automation in R | Magdalena Krochmal & Amy Franklin, Roche | View Now |
Scripts, Macros & Automation | SM02: Same But Different: Leveraging R for Comparing Clinical Study TFL Versions | Tiina Kirsilä, Novartis & Anna Wiksten, Bristol Myers Squibb | View Now |
